|
Volumn 347, Issue 6224, 2015, Pages 825-856
|
Can oxytocin treat autism?: We are still at an early stage of assessing oxytocin-based therapy for autism spectrum disorders
|
Author keywords
[No Author keywords available]
|
Indexed keywords
OXYTOCIN;
OXYTOCIN RECEPTOR;
4 AMINOBUTYRIC ACID;
MELANOCORTIN 4 RECEPTOR;
AUTISM;
BEHAVIOR THERAPY;
BRAIN MATURATION;
CLINICAL TRIAL (TOPIC);
EMPATHY;
GENE MUTATION;
HIPPOCAMPUS;
HUMAN;
INSULA;
NERVE POTENTIAL;
NEUROTRANSMISSION;
NONHUMAN;
NOTE;
OXYTOCIN BLOOD LEVEL;
PHENOTYPE;
PRIORITY JOURNAL;
SIGNAL NOISE RATIO;
SOCIAL BEHAVIOR;
SOCIAL BONDING;
SOCIAL COGNITION;
SOCIAL INTERACTION;
SOCIAL STATUS;
STIMULUS;
TREATMENT RESPONSE;
AGONISTS;
AUTISTIC DISORDER;
COGNITION;
DRUG EFFECTS;
HYPOTHALAMUS;
INTRANASAL DRUG ADMINISTRATION;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
ADMINISTRATION, INTRANASAL;
AUTISTIC DISORDER;
CLINICAL TRIALS AS TOPIC;
COGNITION;
EMPATHY;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
HYPOTHALAMUS;
MOLECULAR TARGETED THERAPY;
OXYTOCIN;
RECEPTOR, MELANOCORTIN, TYPE 4;
SOCIAL BEHAVIOR;
|
EID: 84991948803
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aaa8120 Document Type: Note |
Times cited : (170)
|
References (15)
|